 Hello, I'm Dr. John Feller. I'm the Chief Medical Officer for Halo Diagnostics, and I'd like to talk to you a little bit today about prostate cancer. So you might say, well, why prostate cancer? Well, it turns out, prostate cancer after skin cancer is the second most common diagnosed cancer worldwide. And in addition, it's the second most common cause of cancer death in men after lung cancer. Turns out, one in nine men during his lifetime will be diagnosed with prostate cancer. And about one in 32 men, unfortunately, will still die from their disease. In 2019, we have emergence of a great combination of a screening blood test called the serum PSA, a new type of MRI called multi-parametric MRI of the prostate, MR-targeted biopsy of the prostate gland. And then in the research area, image-guided focal therapy of the prostate gland, including MRI-guided laser focal therapy, that are all very exciting topics that I'd like to discuss with you today.